메뉴 건너뛰기




Volumn 8, Issue 3, 2011, Pages 451-453

Detection of type III secretion system virulence and mutations in gyrA and parC genes among quinolone-resistant strains of Pseudomonas aeruginosa isolated from imported shrimp

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

EID: 79952425151     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2010.0687     Document Type: Article
Times cited : (8)

References (12)
  • 1
    • 0034924146 scopus 로고    scopus 로고
    • Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: Role of target enzyme in mechanism of fluoroquinolone resistance
    • DOI 10.1128/AAC.45.8.2263-2268.2001
    • Akasaka T, Tanaka M, Yamaguchi A, and Sato K. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother 2001;45:2263-2268. (Pubitemid 32664465)
    • (2001) Antimicrobial Agents and Chemotherapy , vol.45 , Issue.8 , pp. 2263-2268
    • Akasaka, T.1    Tanaka, M.2    Yamaguchi, A.3    Sato, K.4
  • 2
    • 0003358488 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • Clinical Laboratory Standards Institute, Wayne, PA: Clinical Laboratory Standards Institute
    • Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20th Informational Supplement. Wayne, PA: Clinical Laboratory Standards Institute, 2010.
    • (2010) 20th Informational Supplement
  • 3
    • 67650714628 scopus 로고    scopus 로고
    • Update on the treatment of Pseudomonas aeruginosa pneumonia
    • El Solh AA and Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother 2009;64:229-238.
    • (2009) J. Antimicrob. Chemother. , vol.64 , pp. 229-238
    • El Solh, A.A.1    Alhajhusain, A.2
  • 4
    • 59849110833 scopus 로고    scopus 로고
    • Role of Pseudomonas aeruginosa type III effectors in disease
    • Engel J and Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009;12:61-66.
    • (2009) Curr. Opin. Microbiol. , vol.12 , pp. 61-66
    • Engel, J.1    Balachandran, P.2
  • 5
    • 0034769748 scopus 로고    scopus 로고
    • Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
    • Feltman H, Schulert G, Khan S, Jain M, Peterson L, and Hauser AR. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 2001;147:2659-2669. (Pubitemid 32976307)
    • (2001) Microbiology , vol.147 , Issue.10 , pp. 2659-2669
    • Feltman, H.1    Schulert, G.2    Khan, S.3    Jain, M.4    Peterson, L.5    Hauser, A.R.6
  • 6
    • 0031879743 scopus 로고    scopus 로고
    • Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria
    • Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 1998;27 Suppl 1: S93-S99. (Pubitemid 28375865)
    • (1998) Clinical Infectious Diseases , vol.27 , Issue.SUPPL.1
    • Hancock, R.E.W.1
  • 8
    • 26444496142 scopus 로고    scopus 로고
    • Antibiotic resistance in bacteria from shrimp farming in mangrove areas
    • DOI 10.1016/j.scitotenv.2005.01.006, PII S0048969705000264
    • Le TX, Munekage Y, and Kato S. Antibiotic resistance in bacteria from shrimp farming in mangrove areas. Sci Total Environ 2005;349:95-105. (Pubitemid 41421067)
    • (2005) Science of the Total Environment , vol.349 , Issue.1-3 , pp. 95-105
    • Le, T.X.1    Munekage, Y.2    Kato, S.-I.3
  • 9
    • 0032930837 scopus 로고    scopus 로고
    • Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa
    • Mouneimne H, Robert J, Jarlier V, and Cambau E. Type II isomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999;43:62-66. (Pubitemid 29069200)
    • (1999) Antimicrobial Agents and Chemotherapy , vol.43 , Issue.1 , pp. 62-66
    • Mouneimne, H.1    Robert, J.2    Jarlier, V.3    Cambau, E.4
  • 10
    • 0032926798 scopus 로고    scopus 로고
    • Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli
    • DOI 10.1093/jac/43.1.61
    • Piddock LJ, Jin YF, Ricci V, and Asuquo AE. Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 1999;43:61-70. (Pubitemid 29045933)
    • (1999) Journal of Antimicrobial Chemotherapy , vol.43 , Issue.1 , pp. 61-70
    • Piddock, L.J.V.1    Jin, Y.-F.2    Ricci, V.3    Asuquo, A.E.4
  • 11
    • 58149197594 scopus 로고    scopus 로고
    • Pseudomonas genome database: Facilitating user-friendly, comprehensive comparisons of microbial genomes
    • Winsor GL, Van Rossum T, Lo R, et al. Pseudomonas Genome Database: facilitating user-friendly, comprehensive comparisons of microbial genomes. Nucleic Acids Res 2009;37: D483-D488.
    • (2009) Nucleic Acids Res. , vol.37
    • Winsor, G.L.1    Van Rossum, T.2    Lo, R.3
  • 12
    • 40549116990 scopus 로고    scopus 로고
    • Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
    • DOI 10.1111/j.1469-0691.2007.01939.x
    • Wong-Beringer A, Wiener-Kronish J, Lynch S, and Flanagan J. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and-resistant clinical isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008;14:330-336. (Pubitemid 351356523)
    • (2008) Clinical Microbiology and Infection , vol.14 , Issue.4 , pp. 330-336
    • Wong-Beringer, A.1    Wiener-Kronish, J.2    Lynch, S.3    Flanagan, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.